Rethinking ovarian cancer III: the past decade and future directions.
This Expert Recommendation article focuses on high-grade serous ovarian carcinoma (HGSC), the dominant cause of ovarian...
Terminal T-cell exhaustion predicts tumor control independent of immunotherapy in ovarian cancer.
- Post category:Gynecologic Cancer
- Reading time:1 min read
This study examined whether exhausted T cells can serve as a prognostic marker in high-grade serous ovarian cancer (HGSC...
Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancer.
- Post category:Gynecologic Cancer
- Reading time:1 min read
This prospective study evaluated circulating tumor cells (CTCs) as a non-invasive biomarker in women with advanced high-...
ctDNA monitoring using tumor-informed copy number analysis.
- Post category:Gynecologic Cancer
- Reading time:2 mins read
This study introduces informCNA, a bioinformatics approach to improve detection of circulating tumor DNA (ctDNA) using s...
Antibody-Drug Conjugates in Gynecologic Oncology: Advances, Challenges, and Future Directions.
- Post category:Gynecologic Cancer
- Reading time:2 mins read
The article is a narrative review of antibody–drug conjugates (ADCs) in gynecologic malignancies. It explains ADC str...
Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.
- Post category:Gynecologic Cancer
- Reading time:2 mins read
This study describes DRUGSENS, an ex vivo functional drug testing platform designed to guide personalized therapy in adv...